Live Evaluations
Therapeutic Options in Vitiligo Treatment: An Evolving Landscape
About
Therapeutic Options in Vitiligo Treatment: An Evolving Landscape
This activity is supported by an educational grant from Incyte.
Learning Objectives
At the completion of this activity, participants should be better able to:
Describe the role of emerging therapies for the treatment and management of vitiligo.
Describe strategies to individualize care when using emerging therapies for vitiligo.
Identify techniques for incorporating emerging vitiligo therapies into everyday practice.
Intended Audience
Faculty
Andrew Alexis, MD, MPH
Vice-Chair for Diversity and Inclusion, Dept. of Dermatology
Professor of Clinical Dermatology
Weill Cornell Medicine
New York, NY
Seemal Desai, MD
Clinical Assistant Professor
Department of Dermatology
University of Texas Southwestern Medical Center
Dallas, TX
Accreditation Statement
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of University of Nevada, Reno School of Medicine and CMEsquared. The University of Nevada, Reno School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation Statement
The University of Nevada, Reno School of Medicine designates this enduring activity for a maximum of 0.50 AMA PRA Category 1 CreditsTM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Disclosures & Disclaimers
Disclosures are as follows:
Grant/Research Support: BMS, LEO, Novartis, Almirall
Consultant: Leo, Galderma, Pfizer, Sanofi- Regeneron
Speakers’ Bureau or Honoraria: Regeneron, SANOFI-Genzyme, Pfizer, BMS
Grant/Research Support: AbbVie, Incyte, Dermavant, AOBiome,
Consultant: Galderma, Almirall, Ferndale, BMS, AbbVie, Verrica, UCB, Ortho, Scientis, EPI, Avita, Eli Lilly, Leo, Pfizer, Incyte, L’Oreal, Beiersdorf, J&J
Speakers’ Bureau or Honoraria: Dermavant, Galderma, Pfizer
The University of Nevada, Reno School of Medicine discloses that all relevant conflicts have been satisfactorily mitigated.